Profile data is unavailable for this security.
About the company
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.
- Revenue in USD (TTM)7.57bn
- Net income in USD708.00m
- Incorporated1996
- Employees46.00k
- LocationQuest Diagnostics Inc500 Plaza DrSECAUCUS 07094-3619United StatesUSA
- Phone+1 (973) 520-2700
- Fax+1 (302) 655-5049
- Websitehttps://www.questdiagnostics.com/
More ▼
Mergers & acquisitions
| Acquired company | DGX:NYQ since announced | Transaction value |
|---|---|---|
| Boyce & Bynum Pathology Laboratories-Clinical laboratory services business | 6.08% | -- |
| Marin General Hospital-Outreach Laboratory Service Operations | 9.99% | -- |
| PhenoPath Laboratories PLLC | -6.40% | -- |
| Oxford Immunotec Global PLC-Laboratory Services Business | -6.50% | 170.00m |
| Reprosource Inc | -6.51% | -- |
Data delayed at least 15 minutes, as of Aug 16 2019 21:02 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemed Corporation | 1.84bn | 200.97m | 6.85bn | 15.71k | 35.56 | 11.01 | 28.37 | 3.73 | 12.09 | 12.09 | 110.57 | 39.05 | 1.82 | 210.10 | 14.39 | 116,971.90 | 19.88 | 13.80 | 24.63 | 17.75 | 31.20 | 30.02 | 10.94 | 7.65 | 0.7772 | 45.34 | 0.1398 | 13.41 | 6.96 | 4.75 | 128.71 | 21.63 | 12.51 | 8.83 |
| Molina Healthcare, Inc. | 17.67bn | 792.00m | 8.57bn | 11.00k | 11.48 | 4.96 | 9.60 | 0.485 | 11.90 | 11.90 | 265.46 | 27.56 | 2.29 | -- | 14.81 | 1,606,636.00 | 10.25 | 1.58 | 25.36 | 3.86 | 17.80 | 14.74 | 4.48 | 0.6301 | -- | 10.50 | 0.4709 | 0.00 | -4.99 | 23.45 | 254.37 | 73.61 | -21.09 | -- |
| Davita Inc | 11.25bn | 547.52m | 9.27bn | 77.70k | 17.59 | 2.35 | 6.96 | 0.8236 | 3.29 | 0.8123 | 67.56 | 24.62 | 0.5718 | 76.48 | 5.84 | 144,842.60 | 3.71 | 4.45 | 5.56 | 5.65 | 28.80 | 29.14 | 6.48 | 6.88 | 1.10 | 2.81 | 0.623 | 0.00 | 4.86 | -0.6183 | -6.17 | -0.1217 | 9.83 | -- |
| Universal Health Services, Inc. | 11.06bn | 794.54m | 13.04bn | 78.70k | 16.92 | 2.42 | 10.16 | 1.18 | 8.71 | 8.77 | 120.83 | 60.95 | 0.9695 | -- | 7.00 | 140,571.40 | 7.11 | 7.35 | 8.25 | 8.69 | -- | -- | 7.33 | 7.54 | 1.17 | 7.45 | 0.4314 | 5.37 | 3.48 | 7.89 | 7.02 | 8.64 | 11.42 | 14.87 |
| Quest Diagnostics Inc | 7.57bn | 708.00m | 13.55bn | 46.00k | 19.53 | 2.49 | 13.05 | 1.79 | 5.15 | 5.29 | 55.07 | 40.44 | 0.6729 | 50.14 | 7.07 | 164,608.70 | 6.32 | 6.77 | 7.45 | 7.80 | 35.10 | 36.99 | 9.39 | 9.20 | 0.7673 | 6.87 | 0.4159 | 34.13 | 1.74 | 1.06 | 8.45 | -2.38 | 10.64 | 10.20 |
| WellCare Health Plans, Inc. | 24.90bn | 523.80m | 13.80bn | 12.00k | 26.28 | 3.00 | 17.92 | 0.5543 | 10.44 | 10.38 | 496.55 | 91.50 | 2.13 | -- | 25.07 | 2,075,100.00 | 4.49 | 3.73 | 8.91 | 6.90 | 98.46 | -- | 2.10 | 1.51 | -- | 8.05 | 0.311 | 0.00 | 20.03 | 16.46 | 39.45 | 20.37 | 19.88 | -- |
| Laboratory Corp. of America Holdings | 11.29bn | 882.70m | 16.23bn | 61.00k | 18.98 | 2.27 | 11.34 | 1.44 | 8.76 | 8.46 | 112.33 | 73.05 | 0.6594 | 36.03 | 5.74 | 185,109.80 | 5.16 | 5.17 | 5.97 | 5.92 | 28.13 | 31.01 | 7.83 | 7.21 | 1.05 | 6.85 | 0.4829 | 0.00 | 9.95 | 14.30 | 31.14 | 10.11 | 13.44 | -- |
| Centene Corp | 69.54bn | 1.28bn | 19.86bn | 47.30k | 15.78 | 1.63 | 10.67 | 0.2856 | 3.04 | 3.04 | 165.70 | 29.39 | 2.20 | -- | 15.02 | 1,470,211.00 | 4.02 | 3.80 | 6.28 | 6.78 | 18.65 | 17.75 | 1.82 | 1.46 | -- | 5.55 | 0.3677 | 0.00 | 24.25 | 40.80 | 28.02 | 41.05 | 83.67 | -- |
Data as of Aug 16 2019. Currency figures normalised to Quest Diagnostics Inc's reporting currency: US Dollar USD
43.48%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Jun 2019 | 14.77m | 10.97% |
| Macquarie Investment Management Business Trustas of 30 Jun 2019 | 7.94m | 5.90% |
| BlackRock Fund Advisorsas of 30 Jun 2019 | 7.28m | 5.40% |
| SSgA Funds Management, Inc.as of 30 Jun 2019 | 6.29m | 4.67% |
| American Century Investment Management, Inc.as of 30 Jun 2019 | 4.85m | 3.60% |
| Fiduciary Management, Inc.as of 30 Jun 2019 | 4.39m | 3.26% |
| Davis Selected Advisers LPas of 30 Jun 2019 | 4.00m | 2.97% |
| Boston Partners Global Investors, Inc.as of 30 Jun 2019 | 3.76m | 2.80% |
| Victory Capital Management, Inc.(Investment Management)as of 30 Jun 2019 | 3.19m | 2.37% |
| Geode Capital Management LLCas of 30 Jun 2019 | 2.09m | 1.55% |
More ▼
Data from 30 Jun 2019 - 30 Jun 2019Source: FactSet Research Systems Inc.
